# Sephience

NDC: 52856-201
Generic name: sepiapterin
Labeler / Manufacturer: PTC Therapeutics Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER
Routes: ORAL
Marketing started: 20250728

FDA application: NDA219666

## Active ingredients

- SEPIAPTERIN: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"52856-201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=52856-201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32ac719c-49f0-4105-9c46-18c19583a5c2